• Selexis SA and OSE Immunotherapeutics Enter Pact contractpharma
    May 26, 2017
    Selexis SA and OSE Immunotherapeutics SA have signed a commercial license agreement that provides OSE Immunotherapeutics with access to high performance research cell banks (RCBs) from the Selexis SUREtechnology Platform.
PharmaSources Customer Service